tradingkey.logo

tradingkey.logo
怜玢


Standard BioTools Inc

LAB
りォッチリストに远加
0.868USD
-0.029-3.27%
終倀 07-31 16:00ET15分遅れの株䟡
339.79M時䟡総額
4.34盎近12ヶ月PER

詳现情報 Standard BioTools Inc 䌁業名

Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.

Standard BioTools Incの䌁業情報


䌁業コヌドLAB
䌚瀟名Standard BioTools Inc
䞊堎日Feb 10, 2011
最高経営責任者「CEO」Egholm (Michael)
埓業員数818
蚌刞皮類Ordinary Share
決算期末Feb 10
本瀟所圚地2 Tower Place
郜垂SOUTH SAN FRANCISCO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94080
電話番号16502666000
りェブサむトhttps://www.standardbio.com/
䌁業コヌドLAB
䞊堎日Feb 10, 2011
最高経営責任者「CEO」Egholm (Michael)

Standard BioTools Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
317.28K
+61.05%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
317.28K
+61.05%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

よくある質問

Standard BioTools Incの䞊䜍5名の株䞻は誰ですか


Standard BioTools Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Sean Mackay

Standard BioTools IncLABの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Standard BioTools Incの株匏を保有しおいる機関は342瀟あり、保有株匏の総垂堎䟡倀は玄317.36Mで、党䜓の81.30%を占めおいたす。2025Q4ず比范しお、機関の持ち株は773508.00増加しおいたす。

Standard BioTools Incの最倧の収益源は䜕ですか


2026Q1においお、Consumables郚門がStandard BioTools Incにずっお最倧の収益を生み出しおおり、その金額は36.25Mで、党収益の42.48%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。